Khiron Life Sciences Corp. (KHRNF)

Khiron Life Sciences Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-30.66	-33.13	-24.04	-36.38	-19.81	-4.54
Depreciation & Amortization	1.96	1.12	1.17	0.94	0.34	0
Other Amortization	-	-	-	-	-	0
Asset Writedown & Restructuring Costs	15.58	15.5	-	-	-	-
Stock-Based Compensation	0.73	2.32	5.72	9.37	3.29	1.21
Other Operating Activities	-2.14	-3.88	-5.44	-0.82	0.08	-
Change in Accounts Receivable	1.42	2.31	0.61	-1.38	0.83	-0.34
Change in Inventory	-0.26	-1.44	-2.07	-0.7	-0.18	-
Change in Accounts Payable	-1.46	-2.83	-1.86	0.85	0.67	0.85
Change in Other Net Operating Assets	-0.18	-0.36	1.39	-1.95	0.01	-0.09
Operating Cash Flow	-15.01	-20.4	-24.53	-30.07	-14.77	-2.91
Capital Expenditures	-2.61	-1.74	-2.69	-6.09	-3.83	-0.29
Cash Acquisitions	-0.34	-0.34	-	-2.83	-1.44	0
Investment in Securities	-	-	27.56	-23.05	-3.95	-
Investing Cash Flow	-3.13	-2.09	24.87	-31.98	-9.22	-0.29
Long-Term Debt Repaid	-	-0.11	-0.56	-1.27	-	-
Net Debt Issued (Repaid)	0.89	-0.11	-0.56	-1.27	-	-
Issuance of Common Stock	-	6.89	12.36	55.58	37.59	5.41
Repurchase of Common Stock	-0.85	-	-0.21	-	-	-
Other Financing Activities	4.9	4.12	0.58	2.69	-	-
Financing Cash Flow	4.93	10.9	12.17	57	37.59	5.41
Foreign Exchange Rate Adjustments	-0.1	-1.14	-0.2	-0.61	-0.39	-0.04
Miscellaneous Cash Flow Adjustments	-0.18	0	-0	-	-	-
Net Cash Flow	-13.49	-12.73	12.3	-5.67	13.2	2.17
Free Cash Flow	-17.62	-22.14	-27.23	-36.17	-18.6	-3.2
Free Cash Flow Margin	-109.17%	-173.07%	-339.60%	-377.46%	-2085.93%	-
Free Cash Flow Per Share	-0.09	-0.14	-0.23	-0.35	-0.38	-0.12
Levered Free Cash Flow	-8.83	-11.48	-18.65	-20.31	-10.31	-
Unlevered Free Cash Flow	-8.55	-11.29	-18.42	-20.31	-10.31	-
Change in Net Working Capital	-2.44	0.15	7.86	2.03	-1.53	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.